Truth is:
Nemo is late at least 12 to 18 months. Later this year, several generic Rx products will be in-licensed in order to increase the revenue. The bottom line will be fixed by reducing head counts.
Bolt is not working and further confuses the organization and the company. Formulation team will be moved from Switzerland to BDU, Canada. Surely half of the position will be cut. Cx Business will be sold later 2021.
A few aesthetic/cosmetic products will be in-licensed early next year. Liquid toxin is a joke and it is 12 months late. GBU organization is about to rebuilt, wait for September.
Have a good afternoon then.